SCIENTIFIC ADVISORY BOARD OF BIOPC2026
Oumeya (Mia) ADJALI
Senior Scientist in Gene Therapy, Head of TaRGeT laboratory
INSERM, France
Alain BECK
Senior Director, Biologics CMC & developability
Institut de Recherche Pierre Fabre, France
Roland BELIARD
Consultant in Biotechnology Development/Manufacturing - Strategy & Operations
Biotech Beliard Consulting, France
Nicola BELTRAMINELLI
Chief Development Officer
Innate Pharma, France
Hervé BROLY
VP Biotech Process Development
ex-Merck Serono, Switzerland
Cédric CHARRETIER
Global Head Vaccine Drug Substance Development, Vaccine CMC Development Supply
Sanofi, France
John CHURCHWELL
Associate Lead Scientist
Cell and Gene Therapy Catapult, UK
Olivier COCHET
Head of Biotech Developpment and Supply
Debiopharm, Switzerland
Hervé de MALLIARD
Chairman
MGA Technologies, France
Michel DEGUELDRE
Lead GT Biophysical Sciences
UCB Pharma, Belgium
Arnaud DELOBEL
R&D Director Strategy & Innovation
Quality Assistance, Belgium
Miliza DIAB
Upstream lab lead - MSAT
Novartis, France
Vincent GRIFFOUL
Senior VP Pharmaceutical Affairs
President A3P Switzerland
Michaël LANERO FIDALGO
Chief Operating Officer
TreeFrog Therapeutics, France
Ferielle PEDRO
Assistant Project Manager
INSERM, France
Alain RACHON
Senior Director Business Development Licensing
Oxford Biomedica, France
Guillaume ROUSSEAU
MSAT Site lead
Sanofi, France
Fabien ROUSSET
Director of Innovation
PolyPeptide Group, France
Luc-Alain SAVOY
Global Pharma Business Development Manager
SGS, Switzerland
Kim WILSON
Business Value Expert - Life Sciences
Dassault Systèmes, USA